Yip B - Search Results

1

Is nevirapine-based therapy discontinuation in hepatitis C co-infected patients a more important mortality determinant than hypersensitivity: authors' reply.

Phillips E, Hayden A, Gutiérrez S, Jahnke N, Yip B, Lima VD, Hogg RS, Harrigan PR, Montaner JS. Phillips E, et al. Among authors: yip b. AIDS. 2008 Feb 19;22(4):548-9. doi: 10.1097/QAD.0b013e3282f4a0ed. AIDS. 2008. PMID: 18301076 No abstract available.

2

Determinants of nevirapine hypersensitivity and its effect on the association between hepatitis C status and mortality in antiretroviral drug-naive HIV-positive patients.

Phillips E, Gutiérrez S, Jahnke N, Yip B, Lima VD, Hogg RS, Harrigan PR, Montaner JS. Phillips E, et al. Among authors: yip b. AIDS. 2007 Jul 31;21(12):1561-8. doi: 10.1097/QAD.0b013e3282170a9d. AIDS. 2007. PMID: 17630551

3

Intermittent use of triple-combination therapy is predictive of mortality at baseline and after 1 year of follow-up.

Hogg RS, Heath K, Bangsberg D, Yip B, Press N, O'Shaughnessy MV, Montaner JS. Hogg RS, et al. Among authors: yip b. AIDS. 2002 May 3;16(7):1051-8. doi: 10.1097/00002030-200205030-00012. AIDS. 2002. PMID: 11953472

4

Survival rates after the initiation of antiretroviral therapy stratified by CD4 cell counts in two cohorts in Canada and the United States.

Chan KC, Yip B, Hogg RS, Montaner JS, O'Shaughnessy MV. Chan KC, et al. Among authors: yip b. AIDS. 2002 Aug 16;16(12):1693-5. doi: 10.1097/00002030-200208160-00020. AIDS. 2002. PMID: 12172096 No abstract available.

5

Is there a baseline CD4 cell count that precludes a survival response to modern antiretroviral therapy?

Wood E, Hogg RS, Yip B, Harrigan PR, O'Shaughnessy MV, Montaner JS. Wood E, et al. Among authors: yip b. AIDS. 2003 Mar 28;17(5):711-20. doi: 10.1097/00002030-200303280-00009. AIDS. 2003. PMID: 12646794

6

Interventional cardiovascular procedures among HIV-infected individuals on antiretroviral therapy 1995-2000.

Braitstein P, Yip B, Heath KV, Levy AR, Montaner JS, Humphries K, Kiely FM, O'Shaughnessy MV, Hogg RS. Braitstein P, et al. Among authors: yip b. AIDS. 2003 Sep 26;17(14):2071-5. doi: 10.1097/00002030-200309260-00008. AIDS. 2003. PMID: 14502010

7

Provider bias in the selection of non-nucleoside reverse transcriptase inhibitor and protease inhibitor-based highly active antiretroviral therapy and HIV treatment outcomes in observational studies.

Wood E, Hogg RS, Heath KV, de la Rosa R, Lee N, Yip B, O'Shaughnessy MV, Montaner JS. Wood E, et al. Among authors: yip b. AIDS. 2003 Dec 5;17(18):2629-34. doi: 10.1097/00002030-200312050-00010. AIDS. 2003. PMID: 14685057

8

Earlier initiation of highly active antiretroviral therapy does not protect against the deleterious effects of non-adherence.

Wood E, Hogg RS, Yip B, Harrigan PR, Montaner JS. Wood E, et al. Among authors: yip b. AIDS. 2004 Dec 3;18(18):2432-4. AIDS. 2004. PMID: 15622322 No abstract available.

9

Rates of antiretroviral resistance among HIV-infected patients with and without a history of injection drug use.

Wood E, Hogg RS, Yip B, Dong WW, Wynhoven B, Mo T, Brumme CJ, Montaner JS, Harrigan PR. Wood E, et al. Among authors: yip b. AIDS. 2005 Jul 22;19(11):1189-95. doi: 10.1097/01.aids.0000176219.48484.f1. AIDS. 2005. PMID: 15990572

10

Hepatitis C coinfection is independently associated with decreased adherence to antiretroviral therapy in a population-based HIV cohort.

Braitstein P, Justice A, Bangsberg DR, Yip B, Alfonso V, Schechter MT, Hogg RS, Montaner JS. Braitstein P, et al. Among authors: yip b. AIDS. 2006 Feb 14;20(3):323-31. doi: 10.1097/01.aids.0000198091.70325.f4. AIDS. 2006. PMID: 16439865

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

538 results

Search Page

Filters